Royal Papworth Hospital

Running trials

• Not yet recruiting

  Diagnosis of Women With ANOCA

  NCT07802457· Source

• Recruiting

  A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension

  NCT07758634· Phase 1/2· Source

• Not yet recruiting

  Exercise Therapy for Women With ANOCA

  NCT07733986· Source

• Recruiting

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· Phase 3· Source

• Recruiting

  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06968845· Phase 2· Source

• Active, not recruiting

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)

  NCT06925750· Phase 2· Source

• Active, not recruiting

  FARAPULSE Workflow Assessment Registry

  NCT06656884· Source

• Recruiting

  A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

  NCT06846554· Phase 2· Source

• Recruiting

  A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

  NCT06559150· Phase 2· Source

• Recruiting

  Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography

  NCT06386185· Source

• Recruiting

  A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

  NCT07491172· Phase 1· Source

• Active, not recruiting

  A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

  NCT06329401· Phase 2· Source

• Active, not recruiting

  A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

  NCT06237335· Phase 2· Source

• Active, not recruiting

  MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06132256· Phase 2· Source

• Active, not recruiting

  Improving Pulmonary Hypertension Screening by Echocardiography

  NCT06038149· Source

• Recruiting

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· Phase 3· Source

• Recruiting

  Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease

  NCT06259019· Source

• Recruiting

  Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades

  NCT06052475· Source

• Active, not recruiting

  TrEatment Approach in the Multimodal Era Registry

  NCT05629052· Source

• Active, not recruiting

  Closed-loop for People Living With Cystic Fibrosis Related Diabetes

  NCT05562492· Source

• Active, not recruiting

  Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

  NCT05501873· Source

• Active, not recruiting

  Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

  NCT05478304· Source

• Recruiting

  AF Ablation With High Power Short Duration RF

  NCT05777551· Source

• Recruiting

  MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)

  NCT05487612· Source

• Recruiting

  Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

  NCT05102019· Source

• Active, not recruiting

  Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)

  NCT06222905· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease4 recruiting
• High blood pressure4 recruiting
• Pulmonary arterial hypertension3 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Atrial fibrillation1 recruiting
• Cystic fibrosis1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Heart failure1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

  NCT06664801· Phase 2· Source

• Completed

  Radial Artery Assessment in Surgical Coronary Revascularisation

  NCT06433960· Source

• Completed

  A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis

  NCT06478706· Phase 2· Source

• Completed

  Cough Reduction in IPF With Nalbuphine ER

  NCT05964335· Phase 2· Source

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Source

• Completed

  ANNE Sensor Monitoring in Cystic Fibrosis

  NCT05941832· Source

• Recruiting

  Impact of Personalised Cardiac Anaesthesia and Cerebral Autoregulation on Neurological Outcomes in Patients Undergoing Cardiac Surgery

  NCT05595954· Source

• Completed

  Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

  NCT05185089· Phase 2· Source

• Completed

  A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

  NCT04896008· Phase 3· Source

• Completed

  Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

  NCT03656926· Phase 3· Source

• Completed

  Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation

  NCT03729830· Source

Trial sites

• Department of Cardiac Surgery, Royal Papworth Hospital1 trial
• Papworth Hospital2 trials
• Royal Papworth Hospital28 trials
• Royal Papworth Hospital - Clincial Research Facility1 trial
• Royal Papworth Hospital, Department of Anaesthesia and Intensive Care1 trial
• Royal Papworth Hospital (Site 1208)1 trial
• Royal Papworth Hospital (Site 1802)2 trials
• Royal Papworth Hospital1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Mesothelioma5 works · 0 trials